Treatment of anemia of chronic kidney disease caused by ANCA associated vasculitis with roxadustat:one case report with a literature review

<正>罗沙司他作为一种里程碑式的新药用于治疗慢性肾脏病（chronic kidney disease,CKD）贫血,临床试验已证实其疗效及安全性,目前临床上已逐渐开始使用。本文报告1例罗沙司他治疗抗中性粒细胞胞质抗体（antineutrophil cytoplasmic antibody,ANCA）相关性血管炎所致CKD贫血患者,该患者在罗沙司他用药前后均使用促红细胞生成素治疗CKD贫血,...

詳細記述

書誌詳細

出版年:	Linchuang shenzangbing zazhi
主要な著者:	Xiao Xiang, Feng Ya, Zhang Ya-lan, Xu Dan, Ma Rong, Mao Nan
フォーマット:	論文
言語:	中国語
出版事項:	Editorial Department of Journal of Clinical Nephrology 2021-01-01
主題:	Roxadustat Erythropoietin Chronic kidney disease Anemia ANCA associated vasculitis
オンライン･アクセス:	http://www.lcszb.com/thesisDetails?columnId=57905582&Fpath=home&index=0